Skip to main content

Table 1 The relative amount of PDI isoforms (PDIome) in selected cancer cell lines

From: Comparison of anti-cancer effects of novel protein disulphide isomerase (PDI) inhibitors in breast cancer cells characterized by high and low PDIA17 expression

No

Cell line

PDI repertoire in cell lysates

Type of cancer

PDIA1

PDIA3

PDIA4

PDIA6

PDIA9

PDIA10

PDIA15

PDIA16

PDIA17

PDIA18

1

LNCaP

1,3,4,6,9,10

Prostate cancer

0.14 ± 0.03

0.35 ± 0.06

0.07 ± 0.02

0.09 ± 0.01

0.12 ± 0.02

0.04 ± 0.00

    

2

PC-3

1,3,4,6,9,15,17

0.20 ± 0.03

0.33 ± 0.07

0.08 ± 0.02

0.13 ± 0.02

0.11 ± 0.03

 

0.03 ± 0.00

 

0.33 ± 0.05

 

3

Du-145

1,3,4,6,9,15,16

0.36 ± 0.04

0.28 ± 0.05

0.14 ± 0.01

0.17 ± 0.02

0.22 ± 0.02

 

0.04 ± 0.01

0.09 ± 0.02

  

4

TRAMP C-2

1,3,4,6,9,15

0.27 ± 0.09

0.37 ± 0.08

0.04 ± 0.02

0.13 ± 0.02

0.06 ± 0.00

 

0.05 ± 0.02

   

5

TRAMP C-1

1,3,4,6,9,15

0.27 ± 0.07

0.51 ± 0.02

0.06 ± 0.01

0.09 ± 0.01

0.04 ± 0.00

 

0.05 ± 0.01

   

6

Lovo

1,3,4,6,9,15

Colon cancer

0.14 ± 0.07

0.39 ± 0.10

0.15 ± 0.05

0.09 ± 0.02

0.21 ± 0.08

 

0.06 ± 0.04

   

7

HT29

1,3,4,6,9,10,15,16,17

0.38 ± 0.05

0.62 ± 0.12

0.20 ± 0.04

0.21 ± 0.05

0.15 ± 0.03

0.03 ± 0.00

0.05 ± 0.01

0.06 ± 0.01

0.36 ± 0.10

 

8

CaCO2

PDI: 1,3,4,6,9,10,16

0.20 ± 0.03

0.27 ± 0.01

0.09 ± 0.01

0.19 ± 0.01

0.17 ± 0.04

0.03 ± 0.00

 

0.09 ± 0.00

  

9

5637

PDI:1,3,4,6,9,10

Urinary/bladder cancer

0.26 ± 0.08

0.35 ± 0.06

0.15 ± 0.02

0.11 ± 0.02

0.06 ± 0.01

0.02 ± 0.00

    

10

MDA MB 231

PDI:1,3,4,6,9,15

Breast cancer

0.14 ± 0.03

0.17 ± 0.09

0.10 ± 0.04

0.16 ± 0.07

0.13 ± 0.03

 

0.05 ± 0.02

   

11

67NR

PDI:1,3,6,15,16

0.13 ± 0.01

0.15 ± 0.03

 

0.14 ± 0.00

  

0.04 ± 0.00

0.12 ± 0.05

  

12

MCF-7

PDI:1,3,4,6,9,10,15,17,18

0.24 ± 0.09

0.13 ± 0.04

0.08 ± 0.01

0.15 ± 0.02

0.21 ± 0.05

0.04 ± 0.01

0.03 ± 0.00

 

0.25 ± 0.12

0.13 ± 0.03

13

4T1

PDI:1,3,4,6,15

0.10 ± 0.03

0.33 ± 0.06

0.03 ± 0.00

0.18 ± 0.03

  

0.05 ± 0.01

   

14

T47D

PDI:1,3,4,6,9,15,16,17

0.53 ± 0.09

0.39 ± 0.13

0.04 ± 0.02

0.10 ± 0.00

0.23 ± 0.02

 

0.05 ± 0.02

0.08 ± 0.00

0.63 ± 0.19

 

15

LLC

PDI:1,3,4,6,15

Lung cancer

0.09 ± 0.03

0.18 ± 0.12

0.02 ± 0.00

0.10 ± 0.02

  

0.04 ± 0.00

   

16

NCI H1703

PDI:1,3,4,6,9,15,16

0.19 ± 0.17

0.23 ± 0.10

0.04 ± 0.02

0.11 ± 0.02

0.15 ± 0.04

 

0.04 ± 0.00

  

0.12 ± 0.00

17

A549

PDI:1,3,4,6,9,15,17

0.15 ± 0.01

0.14 ± 0.01

0.05 ± 0.01

0.15 ± 0.02

0.06 ± 0.01

 

0.03 ± 0.00

 

0.06 ± 0.00

 

18

A427

PDI:1,3,4,6,9,15,16

0.14 ± 0.04

0.20 ± 0.03

0.11 ± 0.05

0.21 ± 0.01

0.07 ± 0.04

 

0.02 ± 0.00

0.07 ± 0.00

  

19

NCI-H358

PDI:1,3,4,6,9,15,16,17,18

0.28 ± 0.12

0.26 ± 0.02

0.07 ± 0.00

0.15 ± 0.02

0.18 ± 0.06

 

0.04 ± 0.01

0.07 ± 0.00

0.14 ± 0.07

0.12 ± 0.00

20

NCI H1299

PDI: 1,3,6,9,15,16

0.02 ± 0.00

0.11 ± 0.01

 

0.08 ± 0.02

0.09 ± 0.01

 

0.03 ± 0.00

0.07 ± 0.00

  

21

A2780

PDI:1,3,4,6,9,15,16

Ovarian cancer

0.10 ± 0.02

0.32 ± 0.11

0.12 ± 0.03

0.15 ± 0.01

0.10 ± 0.03

 

0.06 ± 0.00

0.13 ± 0.00

  

22

HT1080

PDI: 1,3,4,6,9,15,16

Fibrosarcoma

0.19 ± 0.03

0.27 ± 0.04

0.17 ± 0.03

0.17 ± 0.03

0.10 ± 0.03

 

0.04 ± 0.01

0.08 ± 0.00

  
  1. The relative abundance of PDIA isoforms (emPAI%) was calculated by dividing the emPAI value for single protein by the sum of all emPAI values for all proteins detected in the sample and presented as a percentage to the overall composition with SEM. The two cell lines selected for further studies (MDA-MB-231 and MCF-7) and their PDIA1, 3 and 17 emPAI% values were highlighted in bold.